-

Medable to Present at Morgan Stanley Global Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading AI technology platform provider for clinical research, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the Morgan Stanley Global Healthcare Conference in New York City. The presentation will take place on Tuesday, September 9th 7:45 AM Eastern Time.

About Medable

Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our AI-driven platform, including Agent Studio, enhances speed, scale, and patient access in clinical research. Awarded Best Digital Health Solution by the Galien Foundation, Medable’s platform has been deployed in nearly 400 trials in 70 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and was listed for the second year in a row on the Inc. 5000 in 2024.

Contacts

Media Contact:
Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Burak Over, SVP, Corporate Development & Investor Relations, Medable
Burak@medable.com

Industry:

Medable Inc.

Details
Headquarters: Palo Alto, California
CEO: Michelle Longmire
Employees: 350
Organization: PRI
Release Versions
English

Contacts

Media Contact:
Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Burak Over, SVP, Corporate Development & Investor Relations, Medable
Burak@medable.com

Social Media Profiles
Medable on LinkedIn
More News From Medable Inc.

Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical Summit

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for agentic AI clinical development, today announced that its CEO and co-founder, Dr. Michelle Longmire, will be one of three international guest speakers at Japan’s largest pharmaceutical conference, Ubie Pharma Summit (May 13-14, 2026). Longmire will be speaking at the fifth annual event along with Justin Chen, MD, Clinical Specialist at Google for Health, and John Halamka, MD, President of Mayo Clinic Platform....

Medable Introduces AI Agent to Reduce Burden at Research Sites By Assisting Principal Investigators with Oversight of eCOA Data

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today launched Agentic AI for research sites to reduce burden and assist principal investigators (PIs) in oversight and monitoring of electronic clinical outcome assessment (eCOA) data. Medable’s newest agent integrates seamlessly within its eCOA system workflows. Released just after Medable’s TMF and CRA agents, its PI Summary Agent continues the company’s rapid rollout of fun...

Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes required for trial document management. TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical devel...
Back to Newsroom